Chicago Partners Investment Group LLC Kala Pharmaceuticals, Inc. Transaction History

Chicago Partners Investment Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$1.16 - $2.74 $30,738 - $72,607	-26,499 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.62 - $5.43 $21,900 - $45,389	8,359 Added 46.08%	26,499 $69,000
Q2 2021 Aug 02, 2021	BUY	$5.06 - $8.15 $14,269 - $22,983	2,820 Added 18.41%	18,140 $65,000
Q1 2021 Apr 28, 2021	SELL	$6.24 - $9.58 $505 - $775	-81 Reduced 0.53%	15,320 $124,000
Q4 2020 Jan 27, 2021	BUY	$6.28 - $8.79 $96,718 - $135,374	15,401 New	15,401 $114,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $10.2M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

Stay updated on Chicago Partners Investment Group LLC with notifications on news.